Objective To study the possibility of reporting results of identification and susceptibility testing of Gram-negative bacilli the same day as bacteremia is detected by using direct inoculation from positive blood cultures (Bactec 9240) into VITEK GNIþ and GNS-GA cards.
is dependent on which systems are used and a thorough evaluation of each combination is recommended [9] . The VITEK Gram-negative identification plus (GNIþ) card (bioMérieux, La-Balme-Les-Grottes, France) has only recently been introduced to the market (in 1997). Evaluation and comparison studies have been performed [10] [11] [12] , but the accuracy of identification with the VITEK GNIþ card when inoculated directly from positive blood cultures has not been studied so far.
In order to study the possibility of reporting results of identification and susceptibility testing of Gram-negative bacilli on the same day as the bacteremia is detected, we evaluated the accuracy and speed of direct identification (GNIþ card) and susceptibility testing (GNS-GA card) using the VITEK.
M A T E R I A L A N D M E T H O D S
Blood cultures were screened for growth of microorganisms using the Bactec 9240 system (Becton Dickinson, Cockeysville, MD, USA). The study period was daytime on workdays between 15 June 1999 and 29 February 2000. One blood culture set consisted of two Bactec PLUS aerobic/F Ã bottles and one Bactec PLUS anaerobic/F Ã bottle. One bottle per positive set was investigated by the direct VITEK method (aerobic bottle preferable). Only blood culture sets with Gram-negative enteric bacillus-like morphology on microscopy were included. The VITEK instrument was used with software release R06.01.
Identification
Identification was performed using three different methods. By the direct method a 5-mL sample from the positive blood culture bottle was centrifuged at 160 g for 5 min to pellet blood cells and particulate culture material. The supernatant was then centrifuged at 650 g for 10 min to pellet bacteria. This pellet was used for an oxidase test and to make a McFarland no. 1 standard suspension in 1.8 mL of 0.45% saline using the VITEK Colorimeter. The suspension was then inoculated into the VITEK GNIþ card and processed according to the manufacturer's recommendations. The procedure for the standard method of identification was as above, except that a suspension (McFarland no. 1 standard) was made from an overnight agar culture. The routine method for identification of Gram-negative bacteria was based on extensive conventional characterization and was considered to be the standard [13, 14] .
Six Salmonella arizonae/diarizonae strains were used in simulated blood cultures to study the H 2 S reaction of these strains in the GNIþ card by the direct method.
Susceptibility testing
Susceptibility testing was also performed using three different methods. For both the direct method and the standard method, 50-mL samples of the respective McFarland no. 1 standard suspension used for the GNIþ card were diluted in 1.8 mL 0.45% saline and inoculated into the VITEK GNS-GA card. The routine method for susceptibility testing employed Neo-Sensitabs (User's Guide to Neo-Sensitabs, 11 edn, Rosco, Taastrup, Denmark) on Danish Blood agar (SSI Diagnostika, Hillerød, Denmark) using a semi-confluent inoculum and reading after overnight incubation at 37 8C in ambient air. The following antibiotics were tested: ampicillin, cefuroxime, ceftriaxone, ceftazidime, gentamicin, tobramycin and ciprofloxacin. In case of disagreement between the routine tablet diffusion method and the VITEK methods (including when this was due to differences in interpretative breakpoints), the susceptibility of the isolate was retested using the Etest on Mueller Hinton agar (Becton Dickinson) according to the manufacturer's guidelines (AB Biodisk, Etest manual, edn. 2000). The result of the Etest, which uses the same interpretative breakpoints as the VITEK, was taken as the standard.
Definitions and analysis
In each bacteremic episode, only one positive blood culture set of any given species was included (no repeat cultures). Two positive blood culture sets (same species and susceptibility pattern) from the same patient were by definition considered to belong to the same bacteremic episode if the interval between blood culture samplings was 14 days or less. Isolates with unacceptable identification results (probability numbers of <90%) were regarded as not identified [10] , and these isolates described as having a 'Questionable biopattern', or 'Good confidence, marginal separation' were grouped together with the unidentified isolates ('No identification').
Only isolates identified with a probability number !90% were evaluated in the susceptibility testing part of the present study, since the VITEK algorithm for susceptibility testing is dependent on species-specific growth curves. Susceptibility discrepancies were reported as very major errors (false susceptibility), major errors (false resistance) or minor errors (susceptible/resistant vs. intermediate susceptibility).
R E S U L T S
Of 186 blood culture sets included by microscopy, 17 were excluded due to growth of Gram-negative anaerobes (n ¼ 8), Gram-negative fastidious bacilli (n ¼ 4), Gram-positive bacilli (n ¼ 1), or polymicrobial growth (n ¼ 4). The 12 anaerobic or fastidious bacilli did not grow well enough to generate identification and susceptibility data. One Bacillus sp. (Gram-negative on initial Gram stain) and one Enterobacter cloacae-Enterococcus faecalis mixture among four polymicrobial cultures were reported as unidentified. The other three polymicrobial cultures were reported with identification of the bacterium most active biochemically, and with the susceptibility pattern of the most resistant bacterium. Thus, a total of 169 blood culture sets from 165 patients were able to be evaluated for assessment of the accuracy and speed of direct identification and susceptibility testing.
Identification
The oxidase test is a prerequisite for the VITEK identification algorithm. Identical results were obtained with pelleted bacteria (blood cultures) and with colony material (agar plates).
In Table 1 , the direct VITEK method is compared with the routine method. A total of 126 (75%) isolates were correctly identified, 28 (17%) were unidentified, and 15 (9%) were misidentified (all Escherichia coli). The unidentified group consisted of 22 isolates reported as unidentified and six isolates identified to species or genus level with probability numbers <90%. Table 2 shows the results of the five biochemical tests that yielded for most of the aberrant results: urease, H 2 S and utilization of citrate and malonate (false-positive results) and lysine decarboxylase (false-negative results) for the six isolates with probability numbers <90% and the 15 misidentified isolates. A total of 20 of the 21 isolates were E. coli. The 21 isolates were mainly misidentified or achieved probability numbers <90% due to falsepositive reactions in the malonate (n ¼ 17) and the citrate (n ¼ 16) tests. By manually changing positive results to negative for citrate and malonate in the VITEK bionumber, 12 of these 21 isolates were correctly identified by the VITEK database.
Only one of 12 E. coli isolates reported as S. arizonae was H 2 S positive, while all of the six S. arizonae/diarizonae strains from simulated blood cultures tested by the direct method were H 2 S positive. In contrast, the 21 isolates listed in Table 2 showed no false-positive reactions for the urease, H 2 S and citrate tests and only three false-positive malonate tests when tested by the standard VITEK method.
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Susceptibility testing
Of the 169 isolates, 140 (125 correctly identified and 15 misidentified) were able to be evaluated for the direct susceptibility testing method. A total of 29 isolates were excluded, of which 28 were due to probability numbers of <90% or lack of identification, and one was a Serratia marcescens, where the VITEK expert system cautioned about the combination of species and susceptibility pattern found. For the standard susceptibility testing method, 165 (98%) isolates were able to be evaluated, as four isolates with probability numbers <90% were excluded. The overall resistance as determined by the routine method (n ¼ 169) was low: ampicillin 51%, cefuroxime 10%, ceftriaxone 3%, ceftazidime 1%, ciprofloxacin 1%, gentamicin <1%, and tobramycin <1%.
The 140 isolates were able to be evaluated for direct susceptibility testing were assessed for seven antimicrobial agents, resulting in a total of 980 isolate-antimicrobial combinations. VITEK gave correct results for 969 (99%) of these combinations. The 11 discrepancies were as follows: one major error for ciprofloxacin with one E. coli isolate; one major error with another E. coli isolate for ceftazidime, cefuroxime and gentamicin (contamination was ruled out by retesting from the control well of the GNS-GA card); major errors for ampicillin with three misidentified isolates (E. coli); and finally, minor errors with four isolates (one Klebsiella pneumoniae and one E. coli for cefuroxime and two Pseudomonas aeruginosa for ceftriaxone and ceftazidime, respectively). No difference in accuracy was found between correctly identified isolates (99%, 867/875) and misidentified isolates (97%, 102/105). Direct susceptibility testing took from 3 to 14 h. In fact, 85% were completed within 6 h, and of these, 99% were correct.
For the 165 isolates able to be evaluated for the standard susceptibility testing method a correct result was obtained for 1146 (99%) of the 1155 isolate-antimicrobial combinations. Discrepancies were found in nine combinations, five of which involved cefuroxime.
Isolates with both identification and susceptibility data
After 6 and 8 h, direct testing resulted in identifications and susceptibility patterns for 106 and 109 of the 169 isolates, respectively. After both 6 and 8 h, five isolates were misidentified and three isolates yielded false susceptibility testing results, one very major, one major, and one minor error.
D I S C U S S I O N
In Denmark, we have few problems initiating antibiotic treatment based on microscopy of blood cultures with Gram-positive bacteria due to the low incidences of methicillin-resistant Staphylococcus aureus (<1%) and Streptococcus pneumoniae with reduced susceptibility to penicillin (<4%) [15] . This is in contrast to bacteremia caused by Gram-negative enteric bacilli, where susceptibility to antimicrobial agents varies to a greater extent. Consequently, we assessed the accuracy and speed of identification and susceptibility testing using a direct inoculation method, the GNIþ/ GNS-GA cards, as a prelude to exploring the possibility of same-day reporting of identification and antibiotic susceptibility testing of blood cultures positive with Gram-negative bacilli.
In the present study using the direct method, 75% of isolates were correctly identified, which is considerably lower than when testing the same isolates using the standard method, where 96% were correctly identified. It is also lower than the findings of other studies of direct inoculation of positive blood cultures, in which 92-96% were correctly identified [4] [5] [6] , although Waites et al. only found 72% for the rapid MicroScan panel [7] . Comparison with the results of the present study is, however, difficult as different blood culturing systems or identification systems or both were used.
E. coli caused the largest problem of identification in the present study; most of the aberrant identifications were S. arizonae. Two factors gave suspicion of misidentification. First, S. arizonae is seldom a cause of bacteremia and has not hitherto been seen in Denmark; and secondly, 11 of 12 strains misidentified or identified with a low probability number as S. arizonae had negative H 2 S reaction and this reaction is 99% positive for S. arizonae tested conventionally [13] , and was also positive in all six S. arizonae/diarizonae strains tested from simulated blood cultures. Manually changing positive reactions in the citrate and/or malonate tests resulted in correct identification for a majority of E. coli isolates.
By the standard VITEK method, the two misidentifications and two of the four non-identifica-tions due to low probability numbers were also caused by positive malonate tests, pointing at an inherent tendency of the GNIþ card in this regard. The GNIþ card is an enhanced version of the GNI card with faster reporting, improved identification accuracy, and a larger corresponding database [10] . These improvements, however, might have made the GNIþ card more prone to false-positive results. One Danish clinical microbiology laboratory has stopped using the GNIþ card and is using the GNI card instead because of problems with E. coli identification (Jens K Møller, Å rhus University Hospital, personal communication). We find that these results justify a request to the manufacturer to investigate and possibly modify the identification algorithm of the VITEK software.
Two other factors might be the cause of the low percentage of correct identifications. A washing step was not included in the protocol of the present study, in contrast to previous studies [5, 6] . Thus, it is possible that traces of blood culture broth or blood components have interfered with the biochemical reactions.
The results of the antibiotic susceptibility testings were very accurate for both the direct and the standard method and were as good as those found by other investigators [6, 8, 16] . A shortcoming of these results is that the low level of antibiotic resistance in Denmark resulted in only a small number of isolate-antimicrobial combinations that challenged the system.
The present study was initiated to explore the possibility of same-day reporting of preliminary identification and susceptibility results to clinicians. We chose to accept only identifications made in 6 h or less, as at this point 95% of the identifications were correct, and extending the time limit beyond 6 h only increased the percentage of misidentifications. Irrespective of detection time, the direct inoculation into the VITEK of organisms incompatible with the GNIþ card (one Bacillus sp. and 12 anaerobic or fastidious Gram-negative bacilli) did not result in misidentifications, as all were reported as unidentified or nonviable organisms. In the case of the four polymicrobial blood cultures, the VITEK reported one as unidentified, while the three cultures with different Enterobacteriaceae were reported within 6 h with the therapeutically 'appropriate' susceptibility pattern, i.e. the pattern of the most resistant bacterium.
At 6 h the VITEK had reported identifications plus susceptibility patterns of 106 isolates, corresponding to 63% of 169 mono-bacteremic blood cultures with growth of Gram-negative bacilli intended for the GNIþ card. The cost of this was five misidentifications without therapeutic consequences, and three susceptibility testing errors.
A practical advantage of the direct procedure is the fast oxidase test result, which may have direct implications for the choice of pre-emptive antimicrobial chemotherapy, i.e. inclusion of an anti-pseudomonas antibiotic on suspicion of P. aeruginosa bacteremia.
The direct inoculation method from positive blood cultures cannot replace approved methods of identification and susceptibility testing because of the above-mentioned shortcomings of the accuracy of identification, and because the VITEK cannot identify anaerobes, fastidious Gram-negative bacilli, etc., erroneously inoculated after microscopy. But as we believe that same-day reporting of preliminary blood culture results for about twothirds of our patients with Gram-negative bacteremia would ensure better patient management, we plan to work further with this method in order to improve the clinical utility of our microbiological testing.
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